SUBLEASE AGREEMENT Between DEL WEBB CORPORATION As Sublessor And SPECTRUM PHARMACEUTICALS, INC. As SublesseeSublease Agreement • March 10th, 2011 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • Nevada
Contract Type FiledMarch 10th, 2011 Company Industry JurisdictionTHIS LEASE AGREEMENT (this “Lease”) is entered into as of the 19th day of April, 1999, between HENDERSON PROPERTY LIMITED PARTNERSHIP, a Nevada limited partnership, GURNEE VENTURE, L.P., an Illinois limited partnership, and NEWTOWN, L.P., an Illinois limited partnership, as tenants in common (jointly and severally “Landlord”), and DEL WEBB CORPORATION, a Delaware corporation (“Tenant”).
AMENDMENT NO. 2 TO CONSULTING AGREEMENTConsulting Agreement • March 10th, 2011 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMarch 10th, 2011 Company IndustryThis Amendment No. 2 to the Consulting Agreement dated July 1, 2008 (“Agreement”), is hereby entered into and effective as of July 2 2010 (“Amendment No. 2 Effective Date”), by and between Spectrum Pharmaceuticals, Inc., a Delaware corporation, with an office located at 157 Technology Drive, Irvine, California 92618 (“Spectrum”), and Luigi Lenaz, M.D., located at 11 Planetree Court, Newtown, PA 18940 (“Consultant”). Capitalized terms not defined herein shall have the meaning set forth in the Agreement.
CONFIDENTIAL FIRST AMENDMENT TO SUPPLY AGREEMENTSupply Agreement • March 10th, 2011 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 10th, 2011 Company Industry JurisdictionTHIS FIRST AMENDMENT TO SUPPLY AGREEMENT (this “Amendment”), dated as of December 15, 2008 (the “Amendment Date”), is made by and between CELL THERAPEUTICS, INC., a Washington corporation (“CTI”), and BIOGEN IDEC INC., a Delaware corporation (“Manufacturer”).
AMENDMENT NO. 1 TO CONSULTING AGREEMENTConsulting Agreement • March 10th, 2011 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMarch 10th, 2011 Company IndustryThis Amendment No. 1 to the Consulting Agreement dated July 1, 2008 (“Agreement”), is hereby entered into and effective as of March 16, 2010 (“Amendment No. 1 Effective Date”), by and between Spectrum Pharmaceuticals, Inc., a Delaware corporation, with an office located at 157 Technology Drive, Irvine, California 92618 (“Spectrum”), and Luigi Lenaz, M.D., located at 11 Planetree Court, PA 18940 (“Consultant”). Capitalized terms not defined herein shall have the meaning set forth in the Agreement.
SECURITY AGREEMENTSecurity Agreement • March 10th, 2011 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 10th, 2011 Company Industry JurisdictionTHIS SECURITY AGREEMENT (this “Agreement”), dated as of December 15, 2008 (the “Effective Date”), is made by and between RIT ONCOLOGY, LLC, a Delaware limited liability company (“RIT”), and BIOGEN IDEC INC., a Delaware corporation (“BIIB”).
CONFIDENTIAL AMENDED AND RESTATED LICENSE AND COLLABORATION AGREEMENT FOR D-63153 Dated November 5, 2010 (the “Effective Date”) by and between Aeterna Zentaris GmbH (formerly Zentaris GmbH) Weismilllerstrasse 50 D-60314 Frankfurt am Main Germany -...License and Collaboration Agreement • March 10th, 2011 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMarch 10th, 2011 Company IndustryWHEREAS, the Parties desire to amend and restate in its entirety the Agreement (as amended, the “Agreement”) on the terms and conditions set forth herein; and